BamSEC and AlphaSense Join Forces
Learn More

Cocrystal Pharma Inc.

NASDAQ: COCP    
Share price (1/6/25): $2.40    
Market cap (1/6/25): $24.4 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 7 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 6 pages Consulting and Scientific Advisory Board Agreement
12/34/56
EX-10.1
from 10-Q 19 pages License Agreement
12/34/56
EX-10.7
from 10-Q 19 pages Article 1: Definitions
12/34/56
EX-10.1
from 8-K 33 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 10 pages H.C.WAINWRIGHT&CO
12/34/56
EX-10.1
from 8-K 37 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 36 pages Securities Purchase Agreement
12/34/56
EX-10.12
from 10-K 47 pages Exclusive License and Research Collaboration Agreement by and Between Cocrystal Pharma, Inc. and Merck Sharp & Dohme Corp
12/34/56
EX-10.1
from 8-K 3 pages Cocrystal Pharma, Inc. 19805 N. Creek Parkway Bothell, Wa 98011 March 20, 2019
12/34/56
EX-10.1
from 8-K 55 pages Securities Purchase Agreement
12/34/56
EX-10.1
from S-8 18 pages Cocrystal Pharma, Inc. 2015 Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 6 pages Convertible Note
12/34/56
EX-10.1
from 8-K 11 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 4 pages Offer and Position
12/34/56
EX-10.1
from 8-K 8 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 4 pages Contract Chief Financial Officer Agreement
12/34/56
EX-10.1
from 8-K 5 pages Securities Purchase Agreement
12/34/56
EX-10.17
from 10-K/A 3 pages Cocrystal Pharma, Inc. 2015 Equity Incentive Plan, as Amended Non-Qualified Stock Option Agreement for Gerald McGuire Agreement
12/34/56
EX-10.16
from 10-K/A 2 pages Gary Wilcox Advisory Agreement
12/34/56